See also this year's filing and all EDGAR filings for this company.
PDF Report 0001796129_2025_Vincerx_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001796129, Vincerx Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,410,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,595,000 |
| 4 | LiabilitiesCurrent | 5,281,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,013,471 |
| 9 | ResearchAndDevelopmentExpense | 7,767,337 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,649,154 |
| 13 | remainder_ComprehensiveNetIncome | 495,314 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,005,000 |
| 1 | Liabilities | 5,281,000 |
| 2 | Expenses | 23,780,808 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,724,000 |
| 5 | NetIncome | -22,131,654 |
| 6 | ComprehensiveNetIncome | -21,883,997 |
| 7 | BaseVar | 19,605,638 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.40 |
| 9 | EconomicCapitalRatio | 0.890 |